Parthenolide
Supplement
Parthenolide is retained as a catalog identity with independently verified primary-literature context. No qualified exposure model, dose recommendation, efficacy claim, or safety claim is provided.
Pharmacokinetic model
A route-level PK model for parthenolide is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Supplement
- Suggested cadence
- once daily
Research behind this entry
-
Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.
This citation reports a human clinical study involving a formulation or mixture related to Parthenolide; it is not evidence for the isolated compound. The phase I study administered feverfew standardized for…
1 published study referenced in the app, each with a plain-language summary.